hyperkalemia risk

Cutting Potassium Risk: A Breakthrough for Diabetes Patients High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

High-resolution image of a healthcare setting with diverse patients with type 2 diabetes. The image should highlight the positive effects of SGLT-2 inhibitors and GLP-1 receptor agonists on blood potassium levels, featuring a doctor consulting with a patient. Medical equipment and charts displaying potassium levels should be visible.

Cutting Potassium Risk: A Breakthrough for Diabetes Patients

Contributor September 23, 2024

This population-based cohort study investigates the relationship between the use of SGLT-2 inhibitors, GLP-1 receptor agonists, and...